Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Ccr5 δ32"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
MengMeng Xu
Publikováno v:
Cell & Bioscience, Vol 10, Iss 1, Pp 1-6 (2020)
Abstract Background Biomedical technologies have not just improved human health but also assisted in the creation of human life. Since the first birth of a healthy baby by in vitro fertilization (IVF) 40 years ago, IVF has been the mainstay treatment
Externí odkaz:
https://doaj.org/article/2015b269fbe74621b320d251c7284e41
Autor:
de Sá, Nathalia, Teixeira, Sylvia
Different levels of viremia control are observed among HIV-1-infected individuals. Approximately 1% of the HIV-1-seropositive population suppresses viral replication to extremely low or undetectable levels in the absence of antiretroviral therapy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c240a10c36a3764025d919716d2eb9
Autor:
R Shrestha, Rene S. Hendriksen, L Bhatta-Sharma, Bhatta, Shardulendra P. Sherchand, Samendra P. Sherchan, Dipendra Shrestha
Publikováno v:
Nepal Medical College Journal. 22:153-157
The chemokine receptor CCR5 exhibits an important role for the CD-4 mediated entry of HIV-1. Previous studies revealed that Δ32 mutation on the CCR5 gene results in truncated protein and hence confers protection against HIV-1 infection and AIDS prog
Autor:
Mostafa Saadat
Publikováno v:
Croatian Medical Journal
Publikováno v:
Oncotarget
// Junlong Li 1, * , Yuan Peng 2, * , Hui Liu 3 and Qiang Wu 1 1 Department of Medicine and Teaching, Southwest Hospital, Third Military Medical University, Chongqing 400038, China 2 Department of Oncology, Southwest Hospital, Third Military Medical
Publikováno v:
Clinica Chimica Acta; International Journal of Clinical Chemistry
Clinica Chimica Acta
Clinica Chimica Acta
Publikováno v:
Clinical therapeutics. 41(12)
An analysis of 409,693 UK Biobank participants recently published in Nature Medicine identified a relative 21% increase in all-cause mortality among participants who were homozygous for the Δ32 deletion in the C-C motif chemokine receptor 5 gene (CC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365f1e6ceb5370dd369251373fcbf48b
https://doi.org/10.1101/19006619
https://doi.org/10.1101/19006619
Publikováno v:
Chemokine Receptors and AIDS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388198407bc681aa94372e49b82691c5
https://doi.org/10.1201/9780429074974-11
https://doi.org/10.1201/9780429074974-11